Working… Menu

Safety and Effect of Elbasvir/Grazoprevir Combination Therapy in Hemodialysis Patients With Chronic Hepatitis C

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03022006
Recruitment Status : Unknown
Verified April 2017 by Goki Suda, Norte Study Group.
Recruitment status was:  Recruiting
First Posted : January 16, 2017
Last Update Posted : April 12, 2017
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Goki Suda, Norte Study Group

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : March 2019
Study Completion Date : No date given